These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12052968)

  • 21. Recurrent coronary events are not increased in postinfarction patients with methylenetetrahydrofolate reductase gene C677T polymorphism.
    Vulapalli R; Liang C; Zareba W; Moss AJ
    Am J Cardiol; 2001 Jun; 87(11):1289-92. PubMed ID: 11377358
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.
    Zalavras CG; Malizos KN; Dokou E; Vartholomatos G
    Haematologica; 2002 Jan; 87(1):111-2. PubMed ID: 11801474
    [No Abstract]   [Full Text] [Related]  

  • 25. Two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia.
    Tikly M; Zannettou N; Traub B
    S Afr Med J; 2003 Mar; 93(3):161-2. PubMed ID: 12768933
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
    Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
    Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension.
    Garfunkel VA; Porto PI; Garcia SI; Dieuzeide G; Kirszner T; Plotquin Y; Spataro RJ; Gonzalez C; Pirola CJ
    J Hum Hypertens; 2003 May; 17(5):361-4. PubMed ID: 12756410
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
    Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
    An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
    [No Abstract]   [Full Text] [Related]  

  • 30. How folate fights disease.
    Nat Struct Biol; 1999 Apr; 6(4):293-4. PubMed ID: 10201387
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic modulation of homocysteinemia.
    Rozen R
    Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
    Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
    JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
    Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
    Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylenetetrahydrofolate reductase deficiency in four siblings: a clinical, biochemical, and molecular study of the family.
    Tonetti C; Burtscher A; Bories D; Tulliez M; Zittoun J
    Am J Med Genet; 2000 Apr; 91(5):363-7. PubMed ID: 10767000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acrania, MTHFR 677C-->T mutation and role of folate intake.
    Azzena A; Sciortino R; Salmaso R
    Int J Gynaecol Obstet; 1998 May; 61(2):189-90. PubMed ID: 9639227
    [No Abstract]   [Full Text] [Related]  

  • 37. Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.
    Fallon UB; Ben-Shlomo Y
    Neurology; 2003 Feb; 60(3):526-7; author reply 526-7. PubMed ID: 12578952
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia and occlusive retinal vascular disease in type 2 diabetic and non-diabetic subjects.
    Wirta V; Saransaari P; Wirta O; Rantalaiho V; Oja SS; Pasternack A; Koivula T; Lehtimäki T
    Clin Nephrol; 2002 Sep; 58(3):171-8. PubMed ID: 12356186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTHFR 677C-->T mutation and neural-tube defects.
    Rizzari C; Valsecchi MG; Conter V
    Lancet; 1997 Nov; 350(9089):1479-80. PubMed ID: 9371193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.